Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MLNR | O43193 | 1/20 | 0.93 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.93 |
| ▸ | PGR | P06401 | 1/20 | 0.93 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.93 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.93 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.93 |
| ▸ | DRD2 | P14416 | 1/20 | 0.93 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.93 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.93 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.93 |
| ▸ | CNR1 | P21554 | 1/20 | 0.93 |
| ▸ | DRD1 | P21728 | 1/20 | 0.93 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.93 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.93 |
| ▸ | HRH2 | P25021 | 1/20 | 0.93 |
| ▸ | HTR2C | P28335 | 1/20 | 0.93 |
| ▸ | BDKRB2 | P30411 | 1/20 | 0.93 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.93 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.93 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.93 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Indocyanine Green Acid Form SCHEMBL9976691 | 1.00 | MLNR (0.93) | MLNRNR1I2PGRADRB1ADORA3 | |
| Indocyanine Green Acid Form SCHEMBL29714259 | 1.00 | MLNR (0.93) | MLNRNR1I2PGRADRB1ADORA3 | |
| SCHEMBL13127982 | 1.00 | MLNR (0.93) | MLNRNR1I2PGRADRB1ADORA3 | |
| Indocyanine Green Acid Form SCHEMBL30735698 | 1.00 | MLNR (0.93) | MLNRNR1I2PGRADRB1ADORA3 | |
| Indocyanine Green Acid Form SCHEMBL12891571 | 1.00 | MLNR (0.93) | MLNRNR1I2PGRADRB1ADORA3 | |
| SCHEMBL15182433 | 1.00 | MLNR (0.93) | MLNRNR1I2PGRADRB1ADORA3 | |
| Indocyanine Green Acid Form SCHEMBL14198523 | 1.00 | MLNR (0.93) | MLNRNR1I2PGRADRB1ADORA3 | |
| Indocyanine Green Acid Form SCHEMBL1783237 | 0.99 | MLNR (0.91) | MLNRNR1I2PGRADRB1ADORA3 | |
| Indocyanine Green Acid Form SCHEMBL10626491 | 0.99 | MLNR (0.91) | MLNRNR1I2PGRADRB1ADORA3 | |
| Indocyanine Green Acid Form SCHEMBL1783239 | 0.99 | MLNR (0.91) | MLNRNR1I2PGRADRB1ADORA3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11828752-B2 | Protease-activated contrast agents for in vivo imaging | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY | 2023-11-28 | — | — | US | disclosed |
| US-10022459-B2 | Medical tissue-marker and manufacturing method for the same | NATIONAL UNIVERSITY CORPORATION CHIBA UNIVERSITY (JP) | 2018-07-17 | — | — | US | disclosed |
| WO-2018119476-A1 | ACTIVITY-BASED PROBE COMPOUNDS, COMPOSITIONS, AND METHODS OF USE | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2018-06-28 | — | — | WO | disclosed |
| US-9920087-B2 | Dithiolene metal complex colorless IR absorbers | BASF SE (DE) | 2018-03-20 | — | — | US | disclosed |
| US-9890187-B2 | Prototype systems of theranostic biomarkers for in vivo molecular management of cancer | EPOS-IASIS RESEARCH AND DEVELOPMENT, LTD. (CY) | 2018-02-13 | — | — | US | disclosed |
| US-20170333575-A1 | POLYMER AND CONTRAST AGENT FOR PHOTOACOUSTIC IMAGING INCLUDING THE POLYMER | CANON KABUSHIKI KAISHA (JP) | 2017-11-23 | — | — | US | disclosed |
| US-20140219924-A1 | MEDICAL TISSUE-MARKER AND MANUFACTURING METHOD FOR THE SAME | NATIONAL UNIVERSITY CORPORATION CHIBA UNIVERSITY (JP) | 2014-08-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170333575-A1 | POLYMER AND CONTRAST AGENT FOR PHOTOACOUSTIC IMAGING INCLUDING THE POLYMER | PHOSPHO1, PCTP, PAICS | MLNR 1534/4885NR1I2 2522/4885PGR 2181/4885 |
| US-20140219924-A1 | MEDICAL TISSUE-MARKER AND MANUFACTURING METHOD FOR THE SAME | CD63, CD68, PLIN5 | MLNR 3607/4885NR1I2 2245/4885PGR 1220/4885 |
| US-10022459-B2 | Medical tissue-marker and manufacturing method for the same | CD63, CD68, PLIN5 | MLNR 3762/4885NR1I2 2608/4885PGR 1187/4885 |
| US-11828752-B2 | Protease-activated contrast agents for in vivo imaging | CTSV, CTSF, CTSS | MLNR 1410/4885NR1I2 4023/4885PGR 4472/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.